Glucagon App Now Available for Android Devices

A mobile app designed for health care professionals and caregivers of diabetics who may need glucagon treatment is now available for both Android and Apple devices.

A mobile app designed for health care professionals and caregivers of diabetics who may need glucagon treatment is now available for both Android and Apple devices.

Lilly Diabetes' Glucagon app allows those who support type 1 diabetics to practice injecting the drug ahead of a severe low blood sugar episode that requires emergency treatment.

Features of the free app include an injection tutorial, emergency instructions, glucagon kit location log, and expiration date log that alerts the user when a kit is about to reach its expiration date.

"Lilly Diabetes is committed to developing personalized solutions to help people with diabetes achieve their treatment goals and improve their outcomes—including the creation of innovative online tools that provide a range of support," stated Matt Caffrey, senior director of consumer marketing for Lilly Diabetes. "The new version of the Lilly Glucagon mobile app leverages the power of Android mobile

technology, helping us reach even more caregivers and providing another opportunity to support people living with type 1 diabetes."

Glucagon is a treatment for insulin coma or insulin reaction resulting from hypoglycemia. It should not be used by those who have pheochromocytoma or are allergic to glucagon.

Early signs of hypoglycemia include sweating, drowsiness, dizziness, and sleep disturbances. Those who are unable to find a quick source of sugar to treat these low blood sugar symptoms should receive glucagon or intravenous glucose at a medical facility.